Curdione alleviates DSS-induced colitis by inhibiting of M1-like macrophage in mice.
Abstract
Curdione (Cur) has been showed as an effective natural ingredient to possess anti-inflammatory, antioxidant, and anticancer properties. However, its therapeutic effects in colitis remain under-explored. We hypothesized that Cur would alleviate dextran sulfate sodium (DSS)-induced colitis via inhibiting M1-like macrophage. The effect of Cur on mice macrophage was evaluated using flow cytometry, immunofluorescence, and macrophage depletion treatment. Cur reduced colonic and serum pro-inflammatory cytokines and macrophage infiltration in mice during DSS challenge. But such protection could not be recapitulated with macrophage depletion in mice suggesting macrophages are essential for the therapeutic efficacy of Cur in colitis. Mechanistically, Cur restored gut tryptophan metabolic network, enriching Indole-3-ethanol (I3E), 5-Hydroxyindole-3-acetic acid (5-HIAA) and Kynurenic acid (KYNA), which significantly reduced Toll-like receptor 2 (Tlr2) and M1 macrophage marker CD86 expression in colitis mice. Collectively, Cur treatment ameliorated DSS-induced colitis by partially inhibition M1 macrophage polarization, which might be associated with an regulation of tryptophan metabolism and downregulation of Tlr2 expression.